Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Ovarian function following a single administration of depo-medroxyprogesterone acetate (DMPA) at different doses.

Bassol S, Garza-Flores J, Cravioto MC, Diaz-Sanchez V, Fotherby K, Lichtenberg R, Perez-Palacios G.

Fertil Steril. 1984 Aug;42(2):216-22.

PMID:
6235131
2.

Pharmacokinetics of depot medroxyprogesterone acetate contraception.

Mishell DR Jr.

J Reprod Med. 1996 May;41(5 Suppl):381-90. Review.

PMID:
8725700
3.

Depo provera in perspective.

McGoldrick IA.

P N G Med J. 1981 Dec;24(4):274-9. Review.

PMID:
6461984
4.

Depo Provera. Position paper on clinical use, effectiveness and side effects.

Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.

Br J Fam Plann. 1999 Jul;25(2):69-76. Review. Erratum in: Br J Fam Plann 2000 Jan;26(1):52-3.

PMID:
10454658
5.

Toxicology of depot medroxyprogesterone acetate.

Jordan A.

Contraception. 1994 Mar;49(3):189-201. Review.

PMID:
8200213
6.

Use of depo-provera in teens.

Khoiny FE.

J Pediatr Health Care. 1996 Sep-Oct;10(5):195-201. Review.

PMID:
8920351
7.

[Contraception with injectable long-acting preparation depo-provera].

Prilepskaia VN, Kondrikov NI, Tagieva TT.

Akush Ginekol (Mosk). 1995;(3):7-10. Review. Russian.

PMID:
7653732
8.

Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary.

Lumbiganon P.

Contraception. 1994 Mar;49(3):203-9. Review.

PMID:
8200214
9.

Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.

Kaunitz AM.

J Reprod Med. 1996 May;41(5 Suppl):419-27. Review.

PMID:
8725705
10.

Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge.

Chilvers CE.

Drug Saf. 1996 Sep;15(3):212-8. Review.

PMID:
8879975
11.

[Status of bone mineral density after the long-standing application of contraception Depo-Provera].

Zeman S, Havlík P, Zemanová J, Němec D.

Ceska Gynekol. 2013 Jan;78(1):116-24. Review. Czech.

PMID:
23607391

Supplemental Content

Support Center